Last edition
News about "coronavirus COVID-19 treatment drug favipiravir"
Cipla ready to launch COVID-19 treatment drug favipiravir
Cipla is set to launch coronavirus COVID-19 treatment drug favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process
Coronavirus COVID-19 Treatment Drug Favipiravir | 24/07/2020 | By Darshana | 322
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members